| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
2,020,738
|
1,948,215
|
1,891,688
|
1,795,220
| | Cost of Revenue | 1,199,965 | 1,150,934 | 1,111,898 | 1,030,889 | | |
Gross Profit
|
820,773
|
797,281
|
779,790
|
764,331
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 413,204 | 401,746 | 384,951 | 396,771 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others | 41,662 | 39,282 | 39,453 | 35,602 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
365,907
|
356,253
|
355,386
|
331,958
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 11,276 | 9,591 | 8,997 | 3,134 |
|
Earnings Before Interest And Taxes | 377,183 | 365,844 | 364,383 | 335,092 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 377,183 | 365,844 | 364,383 | 335,092 |
|
Income Tax Expense | 92,974 | 87,065 | 87,482 | 83,160 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 284,209 | 278,779 | 276,901 | 251,932 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
284,209
|
278,779
|
276,901
|
251,932
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
284,209
|
278,779
|
276,901
|
251,932
|
|